State Street Corp grew its holdings in Hill-Rom Holdings Inc (NYSE:HRC) by 2.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,681,107 shares of the medical technology company’s stock after buying an additional 43,645 shares during the quarter. State Street Corp owned about 2.55% of Hill-Rom Holdings worth $133,831,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of HRC. Independent Portfolio Consultants Inc. lifted its holdings in shares of Hill-Rom Holdings by 171.5% in the 2nd quarter. Independent Portfolio Consultants Inc. now owns 1,344 shares of the medical technology company’s stock valued at $107,000 after buying an additional 849 shares during the period. Seven Eight Capital LP acquired a new stake in shares of Hill-Rom Holdings in the 2nd quarter valued at approximately $127,000. Acrospire Investment Management LLC lifted its holdings in shares of Hill-Rom Holdings by 43.4% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,983 shares of the medical technology company’s stock valued at $158,000 after buying an additional 600 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Hill-Rom Holdings by 10.2% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,201 shares of the medical technology company’s stock valued at $175,000 after buying an additional 204 shares during the period. Finally, Citigroup Inc. lifted its holdings in shares of Hill-Rom Holdings by 21.1% in the 2nd quarter. Citigroup Inc. now owns 2,483 shares of the medical technology company’s stock valued at $198,000 after buying an additional 433 shares during the period. 82.31% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: “Hill-Rom Holdings Inc (HRC) Stake Increased by State Street Corp” was posted by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/10/22/hill-rom-holdings-inc-hrc-stake-increased-by-state-street-corp.html.

In other Hill-Rom Holdings news, SVP Andreas G. Frank sold 6,870 shares of the company’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $77.48, for a total value of $532,287.60. Following the completion of the sale, the senior vice president now directly owns 16,701 shares in the company, valued at $1,293,993.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Andreas G. Frank sold 3,940 shares of the company’s stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $77.84, for a total value of $306,689.60. Following the completion of the sale, the senior vice president now owns 16,701 shares of the company’s stock, valued at $1,300,005.84. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.

HRC has been the subject of several recent analyst reports. Morgan Stanley raised their price target on Hill-Rom Holdings from $85.00 to $90.00 and gave the company an “overweight” rating in a report on Friday, June 30th. Zacks Investment Research raised Hill-Rom Holdings from a “sell” rating to a “hold” rating in a report on Thursday, August 24th. BidaskClub cut Hill-Rom Holdings from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Needham & Company LLC reduced their price target on Hill-Rom Holdings from $95.00 to $93.00 and set a “buy” rating for the company in a report on Friday, July 28th. Finally, Cantor Fitzgerald set a $86.00 price target on Hill-Rom Holdings and gave the company a “hold” rating in a report on Friday, July 28th. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $86.83.

Hill-Rom Holdings Inc (NYSE:HRC) opened at 81.19 on Friday. The firm has a market capitalization of $5.35 billion, a PE ratio of 47.31 and a beta of 1.19. The company’s 50-day moving average price is $76.37 and its 200 day moving average price is $76.46. Hill-Rom Holdings Inc has a one year low of $50.50 and a one year high of $84.65.

Hill-Rom Holdings (NYSE:HRC) last released its earnings results on Friday, July 28th. The medical technology company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The firm had revenue of $689.10 million during the quarter, compared to the consensus estimate of $695.50 million. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. The firm’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.81 earnings per share. On average, analysts forecast that Hill-Rom Holdings Inc will post $3.82 earnings per share for the current year.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.